Peer-reviewed veterinary case report
Na+/K+-ATPase and BMP-2 levels in benign and malignant dog mammary
By Ozmen, Ozlem·Published in Acta veterinaria Hungarica·2022·Department of Pathology·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Na+/K+-ATPase and bone morphogenetic protein-2 expressions in parenchymal and microenvironmental cells of canine mammary tumours.
- Species:
- dog
Plain-English summary
A study looked at 28 benign and 46 malignant mammary tumors in dogs to understand how certain proteins could help tell the difference between the two. The researchers found that malignant tumors had higher levels of two proteins, Na+/K+-ATPase and BMP-2, compared to benign tumors and normal tissue. This suggests that these proteins might be useful in diagnosing breast cancer in dogs and possibly even in humans. While this research is promising, it’s still early, and more studies are needed to see how these findings can be applied in veterinary medicine.
People also search for: dog mammary tumor symptoms · how to tell if a dog has cancer · treatment for dog breast cancer
Abstract
The most common canine tumour is mammary tumour, which resembles breast cancer in humans. Microenvironment is a crucial factor in the formation of breast cancers. In order to distinguish between benign and malignant canine mammary tumours, this study looked at the immunohistochemical expression of Na+/K+-ATPase and bone morphogenetic protein-2 (BMP-2) in tumour and microenvironmental cells. The aim of this study was to evaluate the expression of Na+/K+-ATPase and BMP-2 in canine mammary tumours and their relationship with malignancy. In this investigation, 10 normal breast tissues were used as controls, and 28 benign and 46 malignant mammary tumours were taken from the archives of the Department of Pathology. The findings showed that malignant tumours expressed more Na+/K+-ATPase and BMP-2 than did normal breast tissue. Both markers had a negative or slight expression in benign tumours, whereas they considerably increased in malignant tumours. Both tumour parenchymal and microenvironmental cells in malignancies expressed Na+/K+-ATPase and BMP-2. Na+/K+-ATPase expression was observed to be more prominent in cells when compared to BMP-2. These findings also suggest that Na+/K+-ATPase and BMP-2 could be employed in the future to help diagnose canine and possibly human breast cancers earlier or as possible targets for treatment.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/36350571/